About Daiichi sankyo deutschland gmbh
Daiichi Sankyo Deutschland GmbH: A Global Pharmaceutical Company
Daiichi Sankyo is a global pharmaceutical company that has been providing innovative and high-quality healthcare solutions for over 100 years. The company was founded in Japan in 1899 and has since expanded its operations to more than 20 countries worldwide, including Germany.
Daiichi Sankyo Deutschland GmbH is the German subsidiary of Daiichi Sankyo Co., Ltd. The company's headquarters are located in Munich, Germany, and it operates several production plants across the country. Daiichi Sankyo Deutschland GmbH is committed to improving patients' lives by developing new drugs and therapies that address unmet medical needs.
The company's main product portfolio includes treatments for cardiovascular diseases, cancer, pain management, and infectious diseases. Some of its most well-known products include LIXIANA® (edoxaban), an oral anticoagulant used to prevent blood clots; Effient® (prasugrel), a platelet inhibitor used to prevent heart attacks; and Crizotinib®, a targeted therapy used to treat certain types of lung cancer.
In addition to its focus on research and development, Daiichi Sankyo Deutschland GmbH also places great importance on corporate social responsibility. The company strives to make a positive impact on society by supporting various initiatives related to healthcare access, education, environmental sustainability, and disaster relief efforts.
One example of the company's commitment to social responsibility is its partnership with the German Cancer Aid organization. Through this partnership, Daiichi Sankyo Deutschland GmbH supports research projects aimed at improving cancer treatment outcomes for patients in Germany.
Another example is the company's participation in the "Green Office" program initiated by the city of Munich. This program encourages companies operating within Munich city limits to adopt environmentally friendly practices such as reducing energy consumption and waste generation.
Overall, Daiichi Sankyo Deutschland GmbH is a leading player in the global pharmaceutical industry, with a strong focus on innovation, quality, and social responsibility. The company's commitment to improving patients' lives and making a positive impact on society sets it apart from its competitors and positions it for continued success in the years to come.